Spandidos Publications style
Kuwamoto K, Takeda Y, Shirai A, Nakagawa T, Takeishi S, Ihara S, Miyamoto Y, Shinzaki S, Ko JH, Miyoshi E, Miyoshi E, et al: Identification of various types of α2-HS glycoprotein in sera of patients with pancreatic cancer: Possible implication in resistance to protease treatment
. Mol Med Rep 3: 651-656, 2010.
APA
Kuwamoto, K., Takeda, Y., Shirai, A., Nakagawa, T., Takeishi, S., Ihara, S. ... Miyoshi, E. (2010). Identification of various types of α2-HS glycoprotein in sera of patients with pancreatic cancer: Possible implication in resistance to protease treatment
. Molecular Medicine Reports, 3, 651-656. https://doi.org/10.3892/mmr_00000311
MLA
Kuwamoto, K., Takeda, Y., Shirai, A., Nakagawa, T., Takeishi, S., Ihara, S., Miyamoto, Y., Shinzaki, S., Ko, J. H., Miyoshi, E."Identification of various types of α2-HS glycoprotein in sera of patients with pancreatic cancer: Possible implication in resistance to protease treatment
". Molecular Medicine Reports 3.4 (2010): 651-656.
Chicago
Kuwamoto, K., Takeda, Y., Shirai, A., Nakagawa, T., Takeishi, S., Ihara, S., Miyamoto, Y., Shinzaki, S., Ko, J. H., Miyoshi, E."Identification of various types of α2-HS glycoprotein in sera of patients with pancreatic cancer: Possible implication in resistance to protease treatment
". Molecular Medicine Reports 3, no. 4 (2010): 651-656. https://doi.org/10.3892/mmr_00000311
